… meta-analysis were conducted to assess vedolizumab real-world effectiveness and safety in
patients with ulcerative colitis (UC) or Crohn’… -world studies of vedolizumab in adult patients …

… this meta-analysis, showed that a dose of vedolizumab up to 10 mg/kg body weight was well
tolerated, and that more patients treated with vedolizumab … Importantly, no significant safety …

… The relative efficacy and safety of vedolizumab compared with other IBD therapies, … In
conclusion, the results of this meta-analysis showed that vedolizumab was significantly more …

… After several years of VDZ use in clinical practice, this systematic review with meta-analysis
aimed to summarise its overall effectiveness and safety for the treatment of CD and UC, by …

… the safety profile over natalizumab in CD treatment. The results of this systematic review and
metaanalysis … for patients with CD treated with vedolizumab as compared to control patients, …

… , the choice of agents is driven by safety. Although in our meta-analysis of induction and
maintenance phase trials of NAT and VEDO, there were no specific safety signals (risk of SAEs, …

… and meta-analysis to compare the efficacy and safety of infliximab and vedolizumab in adult
patients with moderate-to-severe Crohn… Crohn’s disease and seven eligible ulcerative colitis …

… safety outcomes for VDZ.15-23 Two case reports of interest were included.24, 25 We compare
the safety profile established in pooled integrated analysis of … world” safety profile of VDZ. …

… with the general safety of vedolizumab in pregnancy, … vedolizumab. It is possible these
findings are confounded by disease activity, and further prospective cohort studies of vedolizumab …

… safety of vedolizumab (VDZ) in the treatment of inflammatory bowel disease (IBD). Therefore,
this systematic review and meta‑analysis … ) evaluating the efficacy and safety of VDZ in the …